Log In
Print
BCIQ
Print
Print this Print this
 

Plumiaz (Diazepam nasal spray)

  Manage Alerts
Collapse Summary General Information
Company Acorda Therapeutics Inc.
DescriptionProprietary formulation of diazepam as a nasal spray
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationSeizures
Indication DetailsRescue treatment for epileptic seizures; Treat acute repetitive seizures in patients with epilepsy
Regulatory Designation U.S. - Undisclosed Review (Rescue treatment for epileptic seizures)
Partner SK Biopharmaceuticals Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$133.0M

$2.0M

$123.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today